Cargando…

Natural killer cells: a promising immunotherapy for cancer

As a promising alternative platform for cellular immunotherapy, natural killer cells (NK) have recently gained attention as an important type of innate immune regulatory cell. NK cells can rapidly kill multiple adjacent cancer cells through non-MHC-restrictive effects. Although tumors may develop mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chu, Junfeng, Gao, Fengcai, Yan, Meimei, Zhao, Shuang, Yan, Zheng, Shi, Bian, Liu, Yanyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125849/ https://www.ncbi.nlm.nih.gov/pubmed/35606854 http://dx.doi.org/10.1186/s12967-022-03437-0

Ejemplares similares

Chimeric antigen receptor natural killer cells: a promising antitumor immunotherapy
por: Wang, Yan, et al.
Publicado: (2023)

Natural Killer T Cells in Cancer Immunotherapy
por: Nair, Shiny, et al.
Publicado: (2017)

Microphysiological model reveals the promise of memory-like natural killer cell immunotherapy for HIV(±) cancer
por: Ayuso, Jose M., et al.
Publicado: (2023)

Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer
por: Iyoda, Tomonori, et al.
Publicado: (2023)

Natural Killer Cells and Immunotherapy
por: Noh, Ji-Yoon, et al.
Publicado: (2023)

Natural Killer Cell-Based Cancer Immunotherapies: From Immune Evasion to Promising Targeted Cellular Therapies
por: Hofer, Erhard, et al.
Publicado: (2017)

Targeting Natural Killer Cells for Tumor Immunotherapy
por: Zhang, Cai, et al.
Publicado: (2020)

Natural killer cells: the next wave in cancer immunotherapy
por: Chen, Xin, et al.
Publicado: (2022)

Natural killer cell immunotherapy in glioblastoma
por: Hosseinalizadeh, Hamed, et al.
Publicado: (2022)

Natural killer cells in tumor immunotherapy
por: Wang, Dongyao, et al.
Publicado: (2023)

Cord-Blood Natural Killer Cell-Based Immunotherapy for Cancer
por: Zhao, Xiaoyan, et al.
Publicado: (2020)

Author Correction: Microphysiological model reveals the promise of memory-like natural killer cell immunotherapy for HIV(±) cancer
por: Ayuso, Jose M., et al.
Publicado: (2023)

The Promises of Natural Killer Cell Therapy in Endometriosis
por: Hoogstad-van Evert, Janneke, et al.
Publicado: (2022)

The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
por: Rezvani, Katayoun, et al.
Publicado: (2015)

New Directions for Natural Killer T Cells in the Immunotherapy of Cancer
por: Teyton, Luc
Publicado: (2017)

Bioinspired Preservation of Natural Killer Cells for Cancer Immunotherapy
por: El Assal, Rami, et al.
Publicado: (2019)

Pharmacological targeting of natural killer cells for cancer immunotherapy
por: Miyazato, Kiho, et al.
Publicado: (2020)

Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy
por: Shaver, Kari A., et al.
Publicado: (2021)

Next Generation Natural Killer Cells for Cancer Immunotherapy
por: Rossi, Fiorella, et al.
Publicado: (2022)

Cytokine Induced Killer Cells as Promising Immunotherapy for Solid Tumors
por: Sangiolo, Dario
Publicado: (2011)

Cord Blood-Derived Natural Killer Cell Exploitation in Immunotherapy Protocols: More Than a Promise?
por: Damele, Laura, et al.
Publicado: (2022)

In vitro Natural Killer Cell Immunotherapy for Medulloblastoma
por: Fernández, Lucia, et al.
Publicado: (2013)

Natural Killer Cells: Angels and Devils for Immunotherapy
por: Martín-Antonio, Beatriz, et al.
Publicado: (2017)

Modeling Natural Killer Cell Targeted Immunotherapies
por: Lopez-Lastra, Silvia, et al.
Publicado: (2017)

Natural Killer Cells in Immunotherapy: Are We Nearly There?
por: Bachiller, Mireia, et al.
Publicado: (2020)

Natural Killer Cell-Mediated Immunotherapy for Leukemia
por: Allison, Michaela, et al.
Publicado: (2022)

Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors
por: Nayyar, Gaurav, et al.
Publicado: (2019)

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy
por: Bedard, Melissa, et al.
Publicado: (2017)

Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
por: Lupo, Kyle B., et al.
Publicado: (2019)

iPSC-Derived Natural Killer Cells for Cancer Immunotherapy
por: Karagiannis, Peter, et al.
Publicado: (2021)

A Hot Topic: Cancer Immunotherapy and Natural Killer Cells
por: Michel, Tatiana, et al.
Publicado: (2022)

The prospect of genetically engineering natural killer cells for cancer immunotherapy
por: Poon, Angie Yu Ching, et al.
Publicado: (2022)

Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancer
por: Yang, Xinyi, et al.
Publicado: (2022)

Natural killer cells in antitumour adoptive cell immunotherapy
por: Laskowski, Tamara J., et al.
Publicado: (2022)

Anti-Angiogenic Agent Combined with Anti-PD-1 Immunotherapy Showed Activity in Patients With Classical Hodgkin Lymphoma Who Have Failed Immunotherapy: A Retrospective Case Report Study
por: Yan, Zheng, et al.
Publicado: (2021)

Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies
por: Barnes, Samantha A., et al.
Publicado: (2021)

A novel endogenous CD16-Expressing Natural Killer Cell for cancer immunotherapy
por: Cheng, Zih-Fei, et al.
Publicado: (2021)

Natural Killer Cells: A Promising Kit in the Adoptive Cell Therapy Toolbox
por: Xiao, Jiani, et al.
Publicado: (2022)

Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy
por: Gaggero, Silvia, et al.
Publicado: (2021)

Natural Killer Cell Immunotherapy: From Bench to Bedside
por: Domogala, Anna, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9jjpqtfqd8ivjfslfapvhpm46a